PathoQuest is a global CRO specializing in Next Generation Sequencing (NGS)-based biosafety testing through its iDTECT® platform. Offering GMP-compliant assays for viral safety and genetic characterization of cell and gene therapies, vaccines, and biologics, PathoQuest delivers faster, safer, and animal-free Quality Control (QC) testing. With laboratories in Paris (France) and Wayne, PA (USA), the company supports the biopharma industry worldwide. Learn more at www.pathoquest.com.
Join our mailing list to receive exclusive content and offers.